Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 November 2020 | Story Charlene Stanley | Photo Supplied
Dr Innocent Dande, UFS ISG scholar, has been named the 2021 winner of the JSAS Colin Murray Prize for his research on food politics in Zimbabwe.

Dr Innocent’s Dande’s research on the everyday food struggles experienced by residents of poor suburbs in Harare, Zimbabwe, has earned him a coveted research prize from the London-based Journal of Southern African Studies (JSAS) – the leading international journal in its field.   

Start of extended book project
“Winning this award means a great deal for my career plans, especially as I am planning to come up with an extended book project that looks at working classes’ eating habits and foodscapes, or the geographies of food, cooking and eating in lower class suburbs,” says an excited Dr Dande.  His aim is to write a sensorial history of how the working classes ate and enjoyed food in Zimbabwean cities between 1980 and 2019.
“One advantage is that this prize provides me with funding to carry out research. If the JSAS is satisfied with the outcome, their tradition is to publish it,” he says.

Not deterred by lockdown
Dr Dande arrived at the UFS at the same time the COVID-19 lockdown was announced, which saw many of his colleagues hastily returning to their home countries. His decision to stay indirectly led to his application.
“I was spending so much of my time in my room at Kovsie Inn during Level one of the lockdown. Applying for this grant was a way of dealing with the boredom that comes with locking oneself in for too long,” he explains.  
His application was titled, Cooking, the crisis and cuisines: household economies and food politics in Harare (Zimbabwe), 1997-2020, with much of his research focusing on everyday issues affecting ordinary people, in contrast to “high politics and many other topics that ordinarily shout for more attention.” His aim is to write a social history of the Zimbabwean crisis, focusing on “mundane issues such as the cooking and eating of food.” 

Colin Murray Prize background
Colin Murray was a sociologist, anthropologist, and political economist who passed away in October 2013. He taught at various universities in the UK and South Africa and had a special interest in family histories. Carrying a purse of £2 500, the Colin Murray Prize is awarded to an applicant who is within two years of completing his or her PhD, and is meant to assist the winner in engaging in original research in Murray’s fields of interest. 

ISG an intellectually enriching environment
The COVID-19 pandemic may have restricted physical interactions with colleagues, but Dr Dande says he still found the International Studies Group (ISG) an intellectually enriching place. 
“The ISG continued to hold regular and interesting Zoom seminars. Many of my colleagues have also won very prestigious prizes and are in different stages of completing their various projects. Many others have also published in the same journal (JSAS) and many other high-impact journals.” 
He highly values the generous professional advice from his fellow researchers, as well as the input and feedback of ISG Head, Prof Ian Phimister.
“The ISG has shown me that it is possible to dream big and to even contemplate applying for jobs anywhere in the world and not just in Southern Africa,” says Dr Dande.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept